Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ModernaTX, Inc.
Scientific Title
A Phase 2 Randomized Study of Adjuvant Immunotherapy With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab Versus Pembrolizumab Alone After Complete Resection of High-Risk Melanoma